Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07398482 · ClinicalTrials.gov registry record · NA

PrEPwise Pilot Among Black Women in Eastern Virginia

A NA study, sponsored by Boston University.

Not yet
Registry status
NA
Development phase
108
Enrollment target

NCT07398482 is a NA study that has not yet begun recruiting, run by Boston University. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07398482, a NA study, has not yet begun recruiting, sponsored by Boston University.

NOT YET RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

HIV is a virus that affects many people, but Black women in the U.S. are a population at a much higher risk of getting it compared to white women-about 18 times higher. Pre-exposure prophylaxis (PrEP), a medicine if taken as recommended by a clinician can prevent HIV almost completely (99% effective). The problem is that many Black women, especially those living in the Southern U.S., don't know about this medicine called PrEP or find it hard to access it. To address this, healthcare providers sometimes use "decision aids" which are tools, like brochures or videos, designed to help people understand their medical options and make informed choices based on what's important to them. While these tools have worked well for other health issues, they haven't been widely used for preventing HIV. The challenges are doctors do not have enough time to explain PrEP fully to patients during clinic visits and also some Black women do not trust the healthcare system because of a long history of unfair treatment toward Black communities. Community health workers (CHWs) are trained health workers from the same communities as their patients and can facilitate their ability to provide culturally appropriate health education and information consistent with patients' values and needs. Because of this, patients are often more comfortable talking to them. This project aims to test the acceptability and effectiveness of a decision tool to be integrated into HIV testing services to help Black women decide if PrEP is right for them. The investigators are calling this intervention PrEPwise. A tool originally designed for women dealing with opioid addiction will be adapted to fit the needs of Black women living in the South. The long-term goal of this project is to make it easier for Black women to learn about PrEP and decide whether to use it, ultimately helping lower the number of new HIV cases in Black women.

Interventions

  • OTHER Usual care
  • BEHAVIORAL PrEPwise

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2027-04
Est. Completion 2028-07
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT07398482

The ClinicalTrials.gov registry entry for NCT07398482 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT07398482 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07398482 about?

NCT07398482 is a clinical study titled "PrEPwise Pilot Among Black Women in Eastern Virginia". HIV is a virus that affects many people, but Black women in the U.S. are a population at a much higher risk of getting it compared to white women-about 18 times higher. Pre-exposure prophylaxis (PrEP), a medicine if taken as recommended by a clinician can prevent HIV almost completely (99% effective...

What is the current status of trial NCT07398482?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2027-04. Estimated completion is 2028-07.

What interventions are being tested in trial NCT07398482?

The interventions under investigation include: Usual care (OTHER), PrEPwise (BEHAVIORAL).

Who is sponsoring clinical trial NCT07398482?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.